Abstract
An intact skin barrier prevents the penetration of harmful substances from the environment into the skin and prevents occupational skin diseases. In contact dermatitis, the first step in pathology is the disruption of the skin barrier. The skin barrier often gets disrupted by chronic exposure to water plus detergents or solvents. Thereafter, irritants may penetrate into the skin and induce injury to the keratinocyte cell membrane in the living epidermal layers leading to cytokine release and inflammation. Also, allergens may come into contact with Langerhans and T cells and induce immunological reactions and inflammation which lead to allergic contact dermatitis. Treatment strategies should aim to restore the skin barrier to cure and prevent the relapse of the disease. Corticosteroids reduce immunological reactions and inflammation, but do not lead to a complete barrier repair. For long-term treatment of eczema, drugs which improve the skin barrier like pimecrolimus or, in particular, emollients should be preferred.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rosén K, Jontell M, Mobacken H, Rosdahl I (1989) Epidermal Langerhans’ cells in chronic eczematous dermatitis of the palms treated with PUVA and UVB. Acta Derm Venereol 69:200–205
Del Rosso J (2001) Protecting the hand-skin barrier in the workplace. Occup Health Saf 70:116–120
Antezana M, Parker F (2003) Occupational contact dermatitis. Immunol Allergy Clin North Am 23:269–290
Slodownik D, Nixon R (2007) Occupational factors in skin diseases. Curr Probl Dermatol 35:173–189
Fluhr JW, Darlenski R, Angelova-Fischer I, Tsankov N, Basketter D (2008) Skin irritation and sensitization: mechanisms and new approaches for risk assessment. 1. Skin irritation. Skin Pharmacol Physiol 21:124–135
Nielsen JB, Nielsen F, Sørensen JA (2007) Defense against dermal exposures is only skin deep: significantly increased penetration through slightly damaged skin. Arch Dermatol Res 299:423–431
Madison KC (2003) Barrier function of the skin: “la raison d’etre” of the epidermis. J Invest Dermatol 121:231–241
Roop D (1995) Defects in the barrier. Science 267:474
Candi E, Schmidt R, Melino G (2005) The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 6:328–340
Proksch E, Brandner JM, Jensen JM (2008) The skin: an indispensable barrier. Exp Dermatol 17:1063–1072
Bouwstra JA, Pilgrim K, Ponec M (2006) Structure of the skin barrier. In: Elias PM, Feingold KR (eds) Skin barrier. Taylor & Francis, New York, pp 65
Elias PM (1983) Epidermal lipids, barrier function, and desquamation. J Invest Dermatol 80:44s
Gray GM, Yardley HJ (1975) Different populations of pig epidermal cells: isolation and lipid composition. J Lipid Res 16:441–447
Downing DT, Stewart ME, Wertz PW, Colton SW, Abraham W, Strauss J (1987) Skin lipids: an update. J Invest Dermatol 88:2s–6s
Wertz PW (2006) Biochemistry of human stratum corneum lipids. In: Elias PM, Feingold KR (eds) Skin barrier. Taylor & Francis, New York, pp 33
Proksch E, Feingold KR, Elias PM (1992) Epidermal HMG CoA reductase activity in essential fatty acid deficiency: barrier requirements rather than eicosanoid generation regulate cholesterol synthesis. J Invest Dermatol 99:216–220
Brown SJ, Cordell HJ (2008) Are filaggrin mutations associated with hand eczema or contact allergy?–we do not know. Br J Dermatol 158:1383–1384
Elias PM, Feingold KR (2001) Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications. Arch Dermatol 137: 1079–1081
Uchida Y, Hamanaka S (2006) Stratum cormeum ceramides: function, origins, and therapeutic implications. In: Elias PM, Feingold KR (eds) Skin barrier. Taylor & Francis, New York, pp 43
Marekov LN, Steinert PM (1998) Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope. J Biol Chem 273:17763–17770
Swartzendruber DC, Wertz PW, Madison KC, Downing DT (1987) Evidence that the corneocyte has a chemically bound lipid envelope. J Invest Dermatol 88:709
Schurer NY (2002) Implementation of fatty acid carriers to skin irritation and the epidermal barrier. Contact Derm 47:199–205
Nemes Z, Steinert PM (1999) Bricks and mortar of the epidermal barrier. Exp Mol Med 31:5–19
Webb A, Li A, Kaur P (2004) Location and phenotype of human adult keratinocyte stem cells of the skin. Differentiation 72:387–395
Brandner JM, Proksch E (2006) Epidermal barrier function: role of tight junctions. In: Elias PM, Feingold KR (eds) Skin barrier. Taylor & Francis, New York, pp 191
Maretzky T, Reiss K, Ludwig A, Buchholz J, Scholz F, Proksch E, de Strooper B, Hartmann D, Saftig P (2005) ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc Natl Acad Sci USA 102:9182–9187
Maretzky T, Scholz F, Köten B, Proksch E, Saftig P, Reiss K (2008) ADAM10-mediated E-cadherin release is regulated by proinflammatory cytokines and modulates keratinocyte cohesion in eczematous dermatitis. J Invest Dermatol 128: 1737–1746
Trautmann A, Altznauer F, Akdis M, Simon HU, Disch R, Brocker EB, Blaser K, Akdis CA (2001) The differential fate of cadherins during T-cell-induced keratinocyte apoptosis leads to spongiosis in eczematous dermatitis. J Invest Dermatol 117:927–934
Elias PM, Matsuyoshi N, Wu H, Lin C, Wang ZH, Brown BE, Stanley JR (2001) Desmoglein isoform distribution affects stratum corneum structure and function. J Cell Biol 153:243–249
Tunggal JA, Helfrich I, Schmitz A, Schwarz H, Gunzel D, Fromm M, Kemler R, H Krieg T, Nissen CM (2005) E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. EMBO J 24:1146–1156
Jensen JM, Fölster-Holst R, Baranowsky A, Schunck M, Winoto-Morbach S, Neumann C, Schütze S, Proksch E (2004) Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol 122: 1423–1431
Proksch E, Elias PM, Feingold KR (1990) Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in murine epidermis modulation of enzyme content and activation state by barrier requirements. J Clin Invest 85:874
Ishida-Yamamoto A, Iizuka H (1998) Structural organization of cornified cell envelopes and alterations in inherited skin disorders. Exp Dermatol 7:1–10
Jensen JM, Proksch E, Elias PM (2006) The stratum corneum of the epidermis in atopic dermatitis. In: Elias PM, Feingold KR (eds) Skin barrier. Taylor & Francis, New York, pp 569
Brasch J (2009) Current knowledge of host response in human tinea Mycoses 52:304–312
Aberg KM, Man MQ, Gallo RL, Ganz T, Crumrine D, Brown BE, Choi EH, Kim DK, Schröder JM, Feingold KR, Elias PM (2008) Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers. J Invest Dermatol 128:917–925
Gläser R, Meyer-Hoffert U, Harder J, Cordes J, Wittersheim M, Kobliakova J, Fölster-Holst R, Proksch E, Schröder JM, Schwarz T (2009) The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. J Invest Dermatol 129: 641–649
Proksch E, Jensen JM, Elias PM (2003) Skin lipids and epidermal differentiation in atopic dermatitis. Clin Dermatol 21:134
Proksch E, Foelster-Holst R, Jensen JM (2006) Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Sci 43:159–169
Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, O’Regan GM, Watson RM, Cecil JE, Bale SJ, Compton JG, DiGiovanna JJ, Fleckman P, Lewis-Jones S, Arseculeratne G, Sergeant A, Munro CS, El Houate B, McElreavey K, Halkjaer LB, Bisgaard H, Mukhopadhyay S, McLean WH (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38:441–446
Ruether A, Stoll M, Schwarz T, Schreiber S, Fölster-Holst R (2006) Filaggrin loss-of-function variant contributes to atopic dermatitis risk in the population of Northern Germany. Br J Dermatol 155:1093–1094
Weidinger S, Illig T, Baurecht H, Irvine AD, Rodriguez E, Diaz-Lacava A, Klopp N, Wagenpfeil S, Zhao Y, Liao H, Lee SP, Palmer CN, Jenneck C, Maintz L, Hagemann T, Behrendt H, Ring J, Nothen MM, McLean WH, Novak N (2006) Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 118:214–219
Irvine AD, McLean WH (2006) Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis. J Invest Dermatol 126:1200–1202
Compton JG, DiGiovanna JJ, Fleckman P, Lewis-Jones S, Arseculeratne G, Sergeant A, Munro CS, El Houate B, McElreavey K, Halkjaer LB, Bisgaard H, Mukhopadhyay S, McLean WH (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38:441–446
Hanifin JM (2009) Evolving concepts of pathogenesis in atopic dermatitis and other czemas. J Invest Dermatol 129: 320–322
Boralevi F, Hubiche T, Léauté-Labrèze C, Saubusse E, Fayon M, Roul S, Maurice-Tison S, Taïeb A (2008) Epicutaneous aeroallergen sensitization in atopic dermatitis infants – determining the role of epidermal barrier impairment. Allergy 63:205–210
Lerbaek A, Bisgaard H, Agner T, Ohm Kyvik K, Palmer CN, Menné T (2007) Filaggrin null alleles are not associated with hand eczema or contact allergy. Br J Dermatol 157: 1199–1204
Giwercman C, Lerbaek A, Bisgaard H, Menné T (2008) Classification of atopic hand eczema and the filaggrin mutations. Contact Derm 59:257–260
Molin S, Vollmer S, Weiss EH, Ruzicka T, Prinz JC (2009) Filaggrin mutations may confer susceptibility to chronic hand eczema characterized by combined allergic and irritant contact dermatitis. Br J Dermatol 161(4):801–807
Novak N, Baurecht H, Schäfer T, Rodriguez E, Wagenpfeil S, Klopp N, Heinrich BH, Ring J, Wichmann E, Illig T, Weidinger S (2008) Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol 128:1430–1435
Fartasch M, Bassukas ID, Diepgen TL (1992) Disturbed extruding mechanism of lamellar bodies in dry non-eczematous skin of atopics. Br J Dermatol 127:221–227
Friebe K, Effendy I, Löffler H (2003) Effects of skin occlusion in patch testing with sodium lauryl sulphate. Br J Dermatol 148:65–69
Warner RR, Stone KJ, Boissy YL (2003) Hydration disrupts human stratum corneum ultrastructure. J Invest Dermatol 120:275–284
Berger CL, Edelson R (2004) The life cycle of cutaneous T cell lymphoma reveals opportunities for targeted drug therapy. Curr Cancer Drug Targets 4:609–619
Jensen JM, Pfeiffer S, Akaki T, Schröder JM, Kleine M, Neumann C, Proksch E, Brasch J (2007) Barrier function, epidermal differentiation, and human beta-defensin 2 expression in tinea corporis. J Invest Dermatol 127:1720–1727
Sterry W, Künne N, Weber-Matthiesen K, Brasch J, Mielke V (1991) Cell trafficking in positive and negative patch-test reactions: demonstration of a stereotypicmigration pathway. J Invest Dermatol 96:459–462
Kondo H, Ichikawa Y, Imokawa G (1998) Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur J Immunol 28: 769–779
Proksch E, Brasch J, Sterry W (1996) Integrity of the permeability barrier regulates epidermal Langerhans cell density. Br J Dermatol 134:630–638
Proksch E, Brasch J (1997) Influence of epidermal permeability barrier disruption and Langerhans’ cell density on allergic contact dermatitis. Acta Derm Venereol 77: 102–104
Nishijima T, Tokura Y, Imokawa G, Seo N, Furukawa F, Takigawa M (1997) Altered permeability and disordered cutaneous immunoregulatory function in mice with acute barrier disruption. J Invest Dermatol 109:175–182
Jung EG (1963) Nachweis der beginnenden Bichromat-Sensibilisierung von Zementekzematikern mittels des Abrisstests. Berufsdermatosen 11:93–103
Kühl M, Klaschka F (1990). Berufsdermatosen. Urban & Schwarzenberg München, pp 204
Dickel H, Bruckner TM, Erdmann SM, Fluhr JW, Frosch PJ, Grabbe J, Löffler H, Merk HF, Pirker C, Schwanitz HJ, Weisshaar E, Brasch J (2004) The strip-patch test: results of a multicentre study towards a standardization. Arch Dermatol Res 296:212–219
Dickel H, Geier J, Kuss O, Altmeyer P (2008) Strip patch test vs. conventional patch test to detect type IV sensitization in patients with allergic contact dermatitis. J Eur Acad Dermatol Venereol 22:1516–1517
Dickel H, Kamphowe J, Geier J, Altmeyer P, Kuss O (2009) Strip patch test vs. conventional patch test: investigation of dose-dependent test sensitivities in nickel- and chromium-sensitive subjects. J Eur Acad Dermatol Venereol 23(9): 1018–1025
Fernandez MFM, de Mello JF, Pires MC, Vizeu MC (2007) Comparative study of patch test using traditional method vs. prior skin abrading. J Eur Acad Dermatol Venereol 21: 1351–1359
Gebhard KL, Effendy I, Löffler HL (2004) Artificial disruption of skin barrier prior to irritant patch testing does not improve test design. Br J Dermatol 150:82–89
Jensen JM, Pfeiffer S, Witt M, Bräutigam M, Neumann C, Weichenthal M, Schwarz T, Fölster-Holst R, Proksch E (2009) Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol 123:1124–1133
Ghadially R, Halkier-Sörensen L, Elias PM (1992) Effects of petrolatum on stratum corneum structure and function. J Am Acad Dermatol 26:387–396
Loden M, Andersson AC, Lindberg M (1999) Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm). Br J Dermatol 140:264–267
Tabata N, O’Goshi K, Zhen YX, Kligman AM, Tagami H (2000) Biophysical assessment of persistent effects of moisturizers after their daily applications: evaluation of corneotherapy. Dermatology 200:308
Proksch E, Feingold KR, Man MQ, Elias PM (1991) Barrier function regulates epidermal DNA synthesis. J Clin Invest 87:1668–1673
Proksch E, Holleran WM, Menon GK, Elias PM, Feingold KR (1993) Barrier function regulates epidermal lipid and DNA synthesis. Br J Dermatol 128:473–482
Chamlin SL, Frieden IJ, Fowler A, Williams M, Kao J, Sheu M, Elias PM (2001) Ceramide-dominant, barrier repair lipids improve childhood atopic dermatitis. Arch Dermatol 137:1110–1112
Berardesca E, Barbareschi M, Veraldi S, Pimpinelli N (2001) Evaluation of efficacy of a skin lipid mixture in patients with irritant contact dermatitis, allergic contact dermatitis or atopic dermatitis: a multicenter study. Contact Derm 45:280–285
Garnock-Jones KP, Perry CM (2009) Alitretinoin: in severe chronic hand eczema. Drugs 69:1625–1634
Elias PM, Fritsch PO, Lampe M, Williams ML, Brown BE, Nemanic M, Grayson S (1981) Retinoid effects on epidermal structure, differentiation, and permeability. Lab Invest 44(6):531–540
Endo K, Suzuki N, Yoshida O, Sato H, Fujikura Y (2007) The barrier component and the driving force component of transepidermal water loss and their application to skin irritant tests. Skin Res Technol 13:425–435
Kütting B, Drexler H (2003) Effectiveness of skin protection creams as a preventive measure in occupational dermatitis: a critical update according to criteria of evidence-based medicine. Int Arch Occup Environ Health 76:253–259
Zhai H, Maibach HI (2007) Protection from irritants. Curr Probl Dermatol 34:47–57
Saary J, Qureshi R, Palda V, DeKoven J, Pratt M, Skotnicki-Grant S, Holness L (2005) A systematic review of contact dermatitis treatment and prevention. J Am Acad Dermatol 53:845
Winker R, Salameh B, Stolkovich S, Nikl M, Barth A, Ponocny E, Drexler H, Tappeiner G (2009) Effectiveness of skin protection creams in the prevention of occupational dermatitis: results of a randomized, controlled trial. Int Arch Occup Environ Health 82:653–662
Alvarez MS, Brown LH, Brancaccio RR (2001) Are barrier creams actually effective? Curr Allergy Asthma Rep 1: 337–341
Korinth G, Lüersen L, Schaller KH, Angerer J, Drexler H (2008) Enhancement of percutaneous penetration of aniline and o-toluidine in vitro using skin barrier creams. Toxicol In Vitro 22:812–818
Wetzky U, Bock M, Wulfhorst B, John SM (2009) Short- and long-term effects of single and repetitive glove occlusion on the epidermal barrier. Arch Dermatol Res 301: 595–602
Lee JY, Effendy I, Maibach HI (1997) Acute irritant contact dermatitis: recovery time in man. Contact Derm 36: 285–290
Wilhelm KP, Freitag G, Wolff HH (1994) Surfactant-induced skin irritation and skin repair: evaluation of a cumulative human irritation model by noninvasive techniques. J Am Acad Dermatol 31:981–987
Schürer NY, Schwanitz HJ (2004) Prevention and regeneration of barrier disturbances in occupational dermatology. J Dtsch Dermatol Ges 2:895–904
Scott IR, Harding CR (1986) Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment. Dev Biol 115:84–92
Spier HW, Sixt I (1955) Untersuchungen über die Abhängigkeit des Ausfalles der Ekzem-Läppchenprobe von der Hornschichtdicke. Quantiativer Abriß-Epikutantest. Hautarzt 6:152–159
Macheleidt O, Kaiser HW, Sandhoff K (2002) Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. J Invest Dermatol 119:166–173
Ong PY, Leung DY (2006) Immune dysregulation in atopic dermatitis. Curr Allergy Asthma Rep 6:384–389
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Proksch, E., Brasch, J. (2011). Role of the Permeability Barrier in Contact Dermatitis. In: Johansen, J., Frosch, P., Lepoittevin, JP. (eds) Contact Dermatitis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-03827-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-03827-3_6
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-03826-6
Online ISBN: 978-3-642-03827-3
eBook Packages: MedicineMedicine (R0)